Market capitalization | $20.53b |
Enterprise Value | $22.77b |
P/E (TTM) P/E ratio | 47.50 |
EV/FCF (TTM) EV/FCF | 33.49 |
EV/Sales (TTM) EV/Sales | 4.20 |
P/S ratio (TTM) P/S ratio | 3.79 |
P/B ratio (TTM) P/B ratio | 3.11 |
Dividend yield | 0.98% |
Last dividend (FY24) | $2.03 |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
9 Analysts have issued a Steris forecast:
9 Analysts have issued a Steris forecast:
Sep '24 |
+/-
%
|
||
Revenue | 5,423 5,423 |
4%
4%
|
|
Gross Profit | 2,340 2,340 |
3%
3%
|
|
EBITDA | 1,438 1,438 |
4%
4%
|
EBIT (Operating Income) EBIT | 935 935 |
15%
15%
|
Net Profit | 435 435 |
21%
21%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
STERIS Plc (Ireland) engages in the manufacture of medical and surgical equipment. The company was founded on December 22, 2016 and is headquartered in Dublin, Ireland.
Head office | Ireland |
CEO | Daniel Carestio |
Employees | 18,179 |
Founded | 2016 |
Website | www.steris.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.